← Back to Search

Behavioural Intervention

Internet-Based Lifestyle Intervention for Prostate Cancer Survivors (iLIVE Trial)

N/A
Recruiting
Led By Kerri Winters-Stone
Research Sponsored by OHSU Knight Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at baseline, 3 months, 6 months, 12 months
Awards & highlights

iLIVE Trial Summary

This trial tests if an online program (iLIVE) can help prevent frailty and obesity in men with prostate cancer on ADT. It may improve quality of life and reduce falls.

Who is the study for?
This trial is for English-speaking men over 18 with prostate cancer who've had at least 6 months of ADT in the past decade, are obese but not morbidly so (BMI >30 to <50), show signs of frailty, and have internet access. They shouldn't be on a diet or exercise plan, have other active cancers except non-melanoma skin cancer, or any condition that affects weight/body composition like Cushing's syndrome.Check my eligibility
What is being tested?
The iLIVE program is being tested to see if it can help reduce obesity and improve frailty in prostate cancer survivors treated with ADT. It includes an online weight loss plus resistance training intervention compared against standard care through random assignment.See study design
What are the potential side effects?
Since this trial involves lifestyle interventions such as diet changes and exercise rather than medication, side effects may include typical exercise-related issues like muscle soreness or strain.

iLIVE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at baseline, 3 months, 6 months, 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and at baseline, 3 months, 6 months, 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in frailty
Change in inactivity
Change in overweight/obesity
+3 more
Secondary outcome measures
Change in health behaviors
Change in physical functioning
Change in quality of life

iLIVE Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Arm I (iLIVE)Experimental Treatment2 Interventions
ARM I: Patients receive online access to an interactive weight loss website and participate in online group based resistance training sessions (iLIVE) on study. Patients also use a Fitbit fitness tracker and Aria smart scale while on study.
Group II: Arm II (Usual care)Active Control1 Intervention
Patients receive usual care with access to online survivorship and exercise recommendations and use a Fitbit fitness tracker and Aria (registered trademark) smart scale while on study.

Find a Location

Who is running the clinical trial?

OHSU Knight Cancer InstituteLead Sponsor
230 Previous Clinical Trials
2,090,476 Total Patients Enrolled
26 Trials studying Prostate Cancer
2,183 Patients Enrolled for Prostate Cancer
National Cancer Institute (NCI)NIH
13,672 Previous Clinical Trials
40,926,191 Total Patients Enrolled
560 Trials studying Prostate Cancer
506,845 Patients Enrolled for Prostate Cancer
Oregon Health and Science UniversityOTHER
974 Previous Clinical Trials
7,385,662 Total Patients Enrolled
20 Trials studying Prostate Cancer
7,116 Patients Enrolled for Prostate Cancer

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are enrolment opportunities currently available for this experiment?

"As showcased on clinicaltrials.gov, this specific trial is not presently accepting new participants - the first post date being October 1st 2023 with a most recent update of August 21th 2023. However, 1021 other trials are currently in search of qualified individuals."

Answered by AI
~167 spots leftby Sep 2027